Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Bone Marrow Transplantation|February 8, 2022
Optimized cyclosporine starting dose may reduce risk of acute GvHD after allogeneic hematopoietic cell transplantation: a single-center cohort studyJérémie Héritier, Michael Medinger, Dominik Heim, et al.
Swiss Medical Weekly|November 11, 2019
Toxicity associated with PD-1 blockade after allogeneic haematopoietic cell transplantationGuacimara Ortega Sanchez, Frank Stenner, Stephan Dirnhofer, et al.
Frontiers in Oncology|August 28, 2023
Characterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemesSarah Jungius, Franziska C Adam, Kerstin Grosheintz, et al.
Transfusion|December 18, 2018
The value of the post-thaw CD34+ count with and without DMSO removal in the setting of autologous stem cell transplantationNicolai Rohner, Jakob R Passweg, Dimitrios A Tsakiris, et al.
Annals of Hematology|March 28, 2019
Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center studyYves Soltermann, Dominik Heim, Michael Medinger, et al.
Frontiers in Cardiovascular Medicine|May 4, 2023
Case report: mRNA-1273 COVID-19 vaccine-associated myopericarditis: Successful treatment and re-exposure with colchicineLuca Valore, Till Junker, Eva Heilmann, et al.
Investigative Ophthalmology & Visual Science|July 20, 2018
Tear Film Proteomics Reveal Important Differences Between Patients With and Without Ocular GvHD After Allogeneic Hematopoietic Cell TransplantationNadine Gerber-Hollbach, Kim Plattner, Olivia E O'Leary, et al.
In Vivo (Athens, Greece)|November 4, 2020
New-onset Post-transplant Diabetes and Therapy in Long-term Survivors After Allogeneic Hematopoietic Stem Cell TransplantationVera Dalla Via, JÖrg P Halter, Sabine Gerull, et al.
British Journal of Haematology|January 8, 2025
Distinct subtypes of post-transplant lymphoproliferative disorders: CHIP-like mutations in early lesions and substantial mutational differences between EBV-positive and EBV-negative diffuse large B-cell lymphomasVanesa-Sindi Ivanova, Thomas Menter, Ningxuan Cui, et al.
Hematology (Amsterdam, Netherlands)|October 1, 2013
Heterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantationSara C Meyer, Michael Medinger, Jörg P Halter, et al.
Pageof 4